How Big Pharma opens the market to new expensive drugs
Date
2012
Authors
Vitry, A.I.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Website
Citation
Statement of Responsibility
Conference Name
Abstract
New medicines are often marketed on the basis of clinical trials of limited size and duration. So clinical studies of a medicine after it has reached the market (post-marketing studies) can be a useful way to get more data on its benefits or possible adverse effects.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright 2012 the author